FDA Approved: FOSAPREPITANT — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved Baxter's original application for fosaprepitant dimeglumine (fosaprepitant) as an antiemetic to prevent chemotherapy-induced nausea and vomitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• fosaprepitant dimeglumine (fosaprepitant dimeglumine)

Snippet

ORIG AP for FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)